Dr Reddy S Laboratories
Select large caps likely to give good returns in 2021, say analysts
Russia to jointly produce Sputnik V vaccine for Covid with India: Envoy
Pfizer moves US court against Aurobindo Pharma, Dr Reddy's on cancer drug
DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir
Dr Reddy's partners Dept of Biotech for vaccine clinical trials in India

Dr Reddy's Q2 PAT down 30% to Rs 762 crore from Rs 1,092 cr year-ago
USFDA approves Remdesivir as first Covid-19 therapy amid WHO reservations
Dr Reddy's Labs isolates data centre services due to cyber attack
Dr Reddy's launches Famotidine generic product in US to treat acidity
Dr Reddy's gets DCGI nod to conduct Covid-19 vaccine phase 2/3 human trails

Panel urges granting Dr Reddy's permission for Russia vaccine phase 2 trial
Dr Reddy's: Progress in Covid vaccine trials to boost firm's growth outlook
Indian samples of global Covid-19 vaccines need to be larger: Experts
India declines proposal to test Sputnik-V Covid-19 vaccine in large study
Dr Reddy's asked to re-submit Russian vaccine phase-3 trial application
Dr Reddy's asked to resubmit application for trials of Russian vaccine
Dr Reddy's says it aims to cut greenhouse gas emissions by 55% by 2030
Dr Reddy's yet to apply for clinical trials of Sputnik V Covid-19 vaccine
Covid-19: Dr Reddy's to distribute Russian vaccine in India. What we know
Covid-19: Mass production of Sputnik V likely to take several months